Abstract
Left ventricular (LV) hypertrophy is a common condition that profoundly affects morbidity and mortality from cardiovascular diseases, including myocardial infarction, congestive heart failure, and stroke. Noninvasive imaging methods have greatly expanded our ability to evaluate cardiac structural and functional characteristics, and enhanced our understanding of the natural history of L hypertrophy. The etiology of LV hypertrophy is likely due to the effects of multiple genes interacting with other genes and the environment. Although hypertension is recognized as a strong determinant of LV hypertrophy, blood pressure explains only a limited amount of the interindividual variation in LV mass. Moreover, LV hypertrophy occurs in the absence of hypertension, and in some cases precedes its development. Genes encoding proteins involved in the structure of the LV, as well as genes encoding cell signal transduction, hormones, growth factors, calcium homeostasis, and blood pressure, are likely candidates for the development of common forms of LV hypertrophy. An overview of the epidemiology and pathophysiology of LV hypertrophy and dysfunction is provided, in addition to evidence of the genetic basis for LV hypertrophy.
Similar content being viewed by others
References and Recommended Reading
Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613–618.
Devereux RB, Alonso DR, Lutas EM, et al.: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450–458.
Yurenev AP, de Quattro V, Devereux RB: Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy. Am Heart J 1990, 120:928–933.
Shimizu G, Hirota Y, Kita Y, et al.: Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991, 83:1676–1684.
Shimizu G, Zile MR, Blaustein AS, Gassch WH: Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements. Circulation 1985, 71:266–272.
Devereux RB, de Simone G, Pickering TG, et al.: Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998, 31:929–936.
de Simone G, Devereux RB, Koren MJ, et al.: Midwall left ventricular mechanics: an independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996, 93:259–265.
de Simone G, Roman MJ, Koren MJ, et al.: Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension 1999, 33:800–805.
Koren MJ, Mensah GA, Blake J, et al.: Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens 1993, 6:815–23.
Ghali JK, Liao Y, Cooper RS: Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998, 31:1635–1640.
Gardin JM, Wagenknecht LE, Anton-Culver H, et al.: Relationship of cardiovascular risk factors to echocardiographic lef ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995, 92:380–387.
Liebson PR, Grandits G, Prineas R, et al.: Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study TOMHS. Circulation 1993, 87:476–486.
Houghton JL, Smith VE, Strogatz DS, et al.: Effect of African-American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function. Hypertension 1997, 29:706–714.
Devereux RB: Regression of left ventricular hypertrophy. How and why? JAMA 1996, 275:1517–1518.
St. John Sutton M, Epstein JA: Hypertrophic cardiomyopathy —beyond the sarcomere. N Engl J Med 1998, 338:1303–1304.
Bielen E, Fagard R, Amery A: The inheritance of left ventricular structure and function assessed by imaging and Doppler echocardiography. Am Heart J 1991, 21:1743–1749.
Coca A, De la Sierra A: Salt sensitivity and left ventricular hypertrophy. Adv Exper Med Biol 1997, 432:91–101.
Ganau A, Devereux RB, Pickering TG, et al.: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990, 81:25–36.
Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy the Framingham Heart Study. Am J Cardiol 1991, 68:85–89.
Saba PS, Roman MJ, Pini R, et al.: Relation of carotid pressure waveform to left ventricular anatomy in normotensive subjects. J Am Coll Cardiol 1993, 22:1873–1880.
Lind L, Andersson PE, Andren B, et al.: Left ventricular hypertrophy is associated with the insulin resistance metabolic syndrome. J Hypertens 1995, 13:433–438.
Schroeder AP, Sihm I, Mørn B, et al.: Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives. Am J Hypertens 1996, 9:207–215.
Schmieder RE, Langenfeld MRW, Friedrich A, Schobel H:Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996, 94:1304–1309.
Lauer MS, Anderson KM, Kannel WB, Levy D: The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991, 266:231–236.
Levy D, Savage DD, Garrison RJ, et al.: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987, 59:956–960.
Mittmann C, Eschenhagen T, Scholz H: Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc Res 1998, 39:267–275.
Swynghedauw B, Chevalier B, Charlemagne D, et al.: Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process. Cardiovasc Res 1997, 35:6–12. Excellent summary of etiology of hypertrophy, particularly related to calcium transport.
Tardif JC, Rouleau JL: Diastolic dysfunction. Can J Cardiol 1996, 12:389–398.
de Simone G, Devereux RB, Romnan MJ, et al.: Echocardiographic left ventricular mass and electrolyte intake predict subsequent arterial hypertension in initially normotensive adults. Ann Intern Med 1991, 114:202–209.
Post WS, Larson MG, Levy D: Cardiac structural precursors of hypertension. Circulation 1994, 90(suppl):614.
Marian AJ, Roberts R: Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury. Ann Med 1998, 30(suppl 1):24–32. Excellent description of the pathologic process of hypertrophy, and how genetic mutations may cause hypertrophy.
Bonne G, Carrier L, Richard P, et al.: Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 1998, 83:580–593.
Vikstrom KL, Leinwand LA: Contractile protein mutations and heart disease. Curr Opinion Cell Biol 1996, 8:97–105. Provides a comprehensive description of the structure and function of the sarcomeric proteins.
Flesch M, Schiffer F, Zolk O, et al.: Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy. Hypertension 1997, 30:383–391.
Sweeney HL, Feng HS, Yang Z, Watkins H: Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A 1998, 95:14406–14410.
Niimura H, Bachinski LL, Sangwatanaroj S, et al.: Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998, 338:1248–1257.
Solaro RJ, Van Eyk J: Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996, 28:217–230.
Mahaney MC, Williams-Blangero S, Blangero J, Michelle-Leland M: Quantitative genetics of relative organ weight variation in captive baboons. Hum Biol 1993, 65:991–1003.
Post WS, Larson MG, Myers RH, et al.: Heritability of left ventricular mass. The Framingham Heart Study. Hypertension 1997, 30:1025–1028.
Harshfield G, Grim C, Hwang C, et al.: Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. Am J Hypertens 1990, 3:538–543.
Arnett DK, Devereux RB, Hong Y, et al.: Strong heritability of left ventricular mass in hypertensive African-Americans and relative wall thickness in hypertensive whites: The HyperGEN Echocardiography Study. Circulation 1998, 98(suppl 1):658.
Innes BA, McLaughlin MG, Kapuscinski MK, et al.: Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension. Hypertension 1998, 31:741–746.
Liew CC: The Cardiac Gene Unit Website. http//:www.tcgu.med.utoronto.ca.
Estacio RO, Jeffers BW, Havranek EP, et al.: Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus. Am J Hypertens 1999, 12:637–642.
Kauma H, Ikaheimo M, Savolainen MJ, et al.: Variants of renin-angiotensin system genes and echocardiographic left ventricular mass. Eur Heart J 1998, 19:1109–1117.
Karjalainen J, Kujala UM, Stolt AM, et al.: Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999, 34:494–499.
Serneri GG, Modesti PA, Boddi M, et al.: Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res 1999, 85:57–67.
Sagnella GA: Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998, 95:519–529.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arnett, D.K. Genetic contributions to left ventricular hypertrophy. Current Science Inc 2, 50–55 (2000). https://doi.org/10.1007/s11906-000-0058-3
Issue Date:
DOI: https://doi.org/10.1007/s11906-000-0058-3